RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 The Reflex Study: Prevention of Joint Structural Damage at 1 Year with Rituximab in Rheumatoid Arthritis Patients with an Inadequate Response to One or More TNF Inhibitors
JF MD Conference Express
YR 2006
FD SAGE Publications
VO 6
IS 3
SP 13
OP 13
DO 10.1177/155989770600600306
UL http://mdc.sagepub.com/content/6/3/13.2.abstract
AB Previous reports of the Reflex Study 6-month data with rituximab (RTX) indicated that this selective CD20+ B cell targeted therapy can inhibit the radiographic progression of joint structural damage in RA patients with longstanding resistance to one or more TNF inhibitors [Cohen et al. Arthritis Rheum in press).